×
Search your requirement
Search your requirement
Home
Press Releases
Submit Release
Events
Reach Us
Social media
Search
Home
Press Releases
Submit Release
Events
Reach Us
Search
MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing
Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics
Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season
OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award
Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis
ProJenX announces the formation of its Clinical Advisory Board
Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma
NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients
Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits
Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.
Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic
FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma
Featured Press Releases
Transposon announces Phase 2 results for TPN-101 in treating C9orf72-related ALS and frontotemporal dementia
Aptar’s Nasal Unidose System will deliver neffy® (epinephrine nasal spray), the first FDA-approved needle-free treatment for Type I allergic reactions, including anaphylaxis
15 Aug 2024
AptarGroup, Inc. a global leader in drug and consumer product dosing, dispensing and protection
...
Emulate, in Partnership with FUJIFILM Cellular Dynamics, Launches Brain-Chip R1 to Advance Neurological Drug Development
Boehringer Ingelheim launches swine vaccine with advanced protection against Porcine Circovirus Type 2 in the U.S
DARZALEX FASPRO® quadruplet approved in U.S. for transplant-ineligible multiple myeloma patients
Stasis Introduces the First Day-and-Night Supplement System Built for Children Who Take Stimulants
Swisslog Healthcare Launches the Allegro Refrigeration Module and Expands Its Tenutō Cold Chain and Connected Pharmacy Platform
By
Swisslog Healthcare
Swisslog Healthcare
19 Nov 2026
Immorta Bio Demonstrates That SenoMune™-0257-Stimulated T Cells Can Perform “Serial Killing” of Senescent Cells
By
Immorta Bio, Inc
Immorta Bio, Inc
20 Nov 2026
Sonic Incytes Announces a Multi-Year Partnership with Madrigal Pharmaceuticals to Advance Non-Invasive Liver Assessment for MASH
By
Sonic Incytes Medical Corp
Sonic Incytes Medical Corp
20 Nov 2026
Phase 3 Results for XTORO® (Finafloxacin Otic Suspension), 0.3%, in Acute Otitis Externa Published in the Annals of Otology, Rhinology & Laryngology
By
Fonseca Biosciences
Fonseca Biosciences
18 Nov 2026
Thermo Fisher Scientific Launched Gibco™ VaxEvo™ CD 293 Medium to Advance the Production of Adenovirus Vaccines
By
Thermo Fisher
Thermo Fisher
18 Nov 2026
As Employers Face Rising GLP-1 Costs, Looking Beyond Price Becomes Essential
By
US-Rx
US-Rx
17 Nov 2026
Most Popular
Alamar Biosciences Launches NULISAqpcr™ BD-pTau217 Assay: A Breakthrough in Non-Invasive Alzheimer’s Biomarker Detection
By
Alamar Biosciences
Oct 14
Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis
By
Gilead Sciences, Inc.
Aug 20
Avenacy announces launch of Eptifibatide for Injection in the U.S.
By
Avenacy
Apr 29
November
2026
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
User Area
Login page
Registration
Edit Profile
Forgot Password
Discover
About Us
Terms Of Use
Privacy Policy
FAQs
Engage with Us
Search on Site
Post Press Release
Promote Brand
List Your Event
Subscribe to Our Monthly Newsletter
Subscribe to Pharmaceutical Era’s monthly newsletter,
Pharmaceutical Leaders Digest
®, to receive timely updates from across the pharmaceutical industry.
I agree with the
Terms and conditions
×
and the
Privacy policy
×
Please enable the javascript to submit this form
Subscribe
Log in
Username
Show
Remember Me
Log in
Create an account
Forgot your username?
Forgot your password?
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. To find out more, please click
here
.
I understand